Healthcare -
Biotechnology - NASDAQ - US
$ 1.5823
-1.11 %
$ 23.5 M
Market Cap
-0.28
P/E
LGVN - OPERATING EXPENSES
Operating Expenses LGVN - Longeveron Inc.
21.2 M
LAST VALUE
8.51%
2 YEAR CAGR
24.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR